<DOC>
	<DOCNO>NCT01403818</DOCNO>
	<brief_summary>This study assess pharmacokinetic interaction ASP1941 Mitiglinide calcium hydrate healthy volunteer .</brief_summary>
	<brief_title>A Study Assess Effect ASP1941 Mitiglinide Their Plasma Concentration</brief_title>
	<detailed_description>This randomize , open label , four group , two-way crossover design study assess effect drug interaction ASP1941 Mitiglinide calcium hydrate pharmacokinetics separate concomitant administration healthy non-elderly adult male subject .</detailed_description>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Mitiglinide</mesh_term>
	<criteria>Healthy judge investigator/subinvestigator base result physical examination laboratory test Body weight ; ≥50.0 kg , &lt; 80.0 kg Body Mass Index ; ≥17.6 , &lt; 26.4 kg/m2 Written inform consent obtain Received investigational drug within 120 day screen assessment Donated 400 mL whole blood within 90 day , 200 mL whole blood within 30 day , component within 14 day screen assessment Received medication within 7 day hospital admission A deviation assessment criterion physical examination laboratory test screen upon admission History drug allergy With renal , hepatic , gastrointestinal , heart , cerebrovascular respiratory diseases Previous treatment ASP1941</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>ipragliflozin</keyword>
	<keyword>Mitiglinide calcium hydrate</keyword>
	<keyword>Drug-Drug interaction</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>